Skip to content
Thursday, May 26, 2022
HealthCare Africa Magazine

Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine

Africa Health & Wellness Expo ad
  • Home
  • TOPICS
    • INVESTMENTS & FUNDING
    • MERGERS & ACQUISITIONS
    • DISEASES UPDATES
    • HEALTHCARE DELIVERY
    • PHARMA MANUFACTURING
    • PEOPLE NEWS
    • CORONAVIRUS NEWS
    • REGULATORY & POLICY
  • THE MAGAZINE
    • About HealthCare Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • VIDEOS
  • COMPANY PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Ever Medical Technologies partners Digital Afrique Telecom to promote digital health solutions in Africa
  • About 100 generic drugs suspended in Europe after data 'irregularities' uncovered at Indian CRO
  • Roche develops three new PCR test kits for monkeypox virus as cases rise
  • Moroccan healthtech startup Blink Pharma bags funding to advance expansion plans
  • Kenya Medical Supplies Authority launches credit control strategy to boost service delivery capacity
  • Eli Lilly boosts manufacturing capacity with US$2.1B investment in Indiana, USA
  • Advocate Aurora Health sued over alleged price inflation
  • Kenya secures US$24M from USAID to improve sanitation
  • Egyptian health and wellness platform Esaal raises US$1.7M to expand access to healthcare
  • Uganda’s President Museveni commissions marine ambulance services
You are here
  • Home
  • Alzheimer’s disease

Tag: Alzheimer’s disease

Biogen withdraws application for Alzheimer’s drug in Europe

24 April 202224 April 2022

EUROPE – Biogen has withdrawn its application for the Alzheimer’s disease drug in the European Union after discussions with regulators revealed that the data provided thus far is unlikely to…

Read More

Fujifilm develops artificial intelligence tech for predicting Alzheimer’s progression

19 April 202219 April 2022

JAPAN – Fujifilm Corporation has developed artificial intelligence technology that can predict whether patients with mild cognitive impairment will develop Alzheimer’s disease (AD) within two years. According to a press…

Read More

Medicare finalizes restrictions on Biogen Alzheimer’s drug

8 April 20228 April 2022

USA – Medicare will not pay for Biogen’s new Alzheimer’s drug unless prospective patients are enrolled in a clinical trial, the US government has announced, severely limiting the drug’s use.…

Read More

Biogen begins downsizing staff following disastrous debut of its Alzheimer’s drug

4 March 20224 March 2022

USA – Biogen has begun to lay off employees as part of a previously announced effort to cut annual expenses by US$500 million. The move comes as the Cambridge, Massachusetts-based…

Read More

Lilly slacks off FDA submission of Alzheimer’s drug after CMS decision on Aduhelm

7 February 20227 February 2022

USA – Eli Lilly has pushed back the deadline for submitting an application for U.S. approval of its experimental Alzheimer’s disease drug, revealing that it will now complete the filing…

Read More

More Federal regulators launch probe into Biogen’s Aduhelm

7 February 20227 February 2022

USA – The Federal Trade Commission (FTC) and the Securities and Exchange Commission (SEC) have opened separate investigations into Biogen Inc and its Alzheimer’s medication, Aduhelm (aducanumab). According to the…

Read More

Takeda, Denali’s Alzheimer’s candidate drug hits regulatory drawback

17 January 202217 January 2022

USA – The FDA has placed a clinical hold on Denali Therapeutics’ Alzheimer’s drug before it even enters human trials. The decision has an impact on Takeda, which only recently…

Read More

GSK takes aim at CNS diseases with University of Oxford partnership

9 December 20219 December 2021

UNITED KINGDOM – GSK and Oxford have launched a five-year collaboration aimed at accelerating R&D breakthroughs in a variety of difficult-to-treat diseases such as Alzheimer’s and Parkinson’s through the use…

Read More

Novartis pays US$150 million to gain rights to UCB’s Parkinson’s drug

9 December 20219 December 2021

BELGIUM – Novartis is putting US$150 million into a Parkinson’s disease drug candidate that is competing with drugs in development at companies such as Roche and AstraZeneca. Novartis will pay…

Read More

First nasal vaccine against Alzheimer’s disease enters human trial phase

30 November 202130 November 2021

USA – Clinical trial for Alzheimer’s disease (AD) nasal vaccine has been launched to see whether a potential treatment could be safe for humans after the therapy showed positive results…

Read More

LATEST DIGITAL MAGAZINE

Africa Health & Wellness Expo ad

Popular Posts Recent Posts

AAR Healthcare unveils new ultra-modern 140-bed capacity hospital

Ghanaian startup Yemaachi secures US$3M seed funding to advance cancer research

Lilly announces the Institute for Genetic Medicine and US$700 million investment

FDA OK’s Quantum’s Epione robot for liver cancer

Africa’s journey to healthcare independence, as fueled by effects of the ongoing pandemic

Ever Medical Technologies partners Digital Afrique Telecom to promote digital health solutions in Africa

About 100 generic drugs suspended in Europe after data ‘irregularities’ uncovered at Indian CRO

Roche develops three new PCR test kits for monkeypox virus as cases rise

Moroccan healthtech startup Blink Pharma bags funding to advance expansion plans

Kenya Medical Supplies Authority launches credit control strategy to boost service delivery capacity

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Biogen Cancer CDC China COVAX Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS India Investments & Funding Japan Johnson & Johnson Kenya Malaria Manufacturing Merck Moderna MOH Kenya Nigeria Novartis Pfizer Pharmaceuticals Roche Sanofi Science & Technology South Africa Switzerland Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

HealthCare Africa MagazineFollow

Africa's No. 1 magazine that showcases the people, businesses and market trends in the pharmaceuticals, healthcare and biotech sectors in Africa & the World

HealthCare Africa Magazine
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 26, 2022

Dr.Tedros Adhanon re-elected as head of @WHO
https://t.co/fjyembNxwX #healthtech #innovation #healthcaredelivery #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment

Reply on Twitter 1529739837556903936Retweet on Twitter 1529739837556903936Like on Twitter 15297398375569039361Twitter 1529739837556903936
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 26, 2022

#regulatory #policies #funding #investment #education

Reply on Twitter 1529735664652124160Retweet on Twitter 1529735664652124160Like on Twitter 1529735664652124160Twitter 1529735664652124160
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 26, 2022

Kenya boosts access to medical care with new laboratory and ultramodern mortuary
https://t.co/D1JmDfQPR2
#health #healthtech #innovation #healthcaredelivery #technology #healthcare #investments #laboratory #medical #referrals #Kenya

Reply on Twitter 1529722987930390528Retweet on Twitter 1529722987930390528Like on Twitter 1529722987930390528Twitter 1529722987930390528
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 26, 2022

Mozambique receives US$404M financing from US in the fight against HIV/AIDS @UNAIDS @PEPFAR @M
https://t.co/XqFl4cgRkd
#HIV #AIDS #digitalhealth #healthtech #innovation #healthcaredelivery #Mozambique #treatment #health #regulatory #policies #funding #Africa #UnitedStates

Reply on Twitter 1529721045397258241Retweet on Twitter 15297210453972582413Like on Twitter 1529721045397258241Twitter 1529721045397258241
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 26, 2022

Uganda’s President Museveni commissions marine ambulance services to provide emergency medical response assistance and services @MinofHealthUG
https://t.co/6P04JT7zB6
#Ambulance #health #innovation #healthcaredelivery #healthscience #Emergency #healthcare #investments #Uganda

Reply on Twitter 1529718065662926848Retweet on Twitter 1529718065662926848Like on Twitter 15297180656629268481Twitter 1529718065662926848
Load More...

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa magazine

Food Business Africa magazine

Food Safety Africa magazine

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.